Title: Chiral Pharmaceutical Intermediaries Obtained by Reduction of 2-Halo-1-(4-substituted phenyl)-ethanones Mediated by Geotrichum candidum CCT 1205 and Rhodotorula glutinis CCT 2182.
Journal: Enzyme research 20110101
100760-04-1
2077-19-2
5391-88-8
194721-56-7
1955530-22-9 | {5H,6H,7H-cyclopenta[b]pyridin-7-yl}methanamine dihydrochloride | AA01B2OQ | MFCD29991713
886578-15-0 | 1H-indole-3-sulfonyl chloride | AA01B312 | MFCD09909936
753454-46-5 | 2-(BICYCLO[2.2.1]HEPTAN-2-YL)ETHANE-1-SULFONYL CHLORIDE | AA01B3G1 | MFCD26064589
1339391-39-7 | 1-(oxan-4-yl)-1H-pyrazol-3-amine | AA01B3WN | MFCD19611488
1955547-82-6 | 2-(4-methylpyridin-3-yl)acetic acid hydrochloride | AA01B4QF | MFCD29991786
1085526-21-1 | tert-Butyl(imino)methyl-lambda6-sulfanone | AA01B4UW | MFCD30497495
76928-54-6 | 2-ethynyloxolane | AA01B4Y6 | MFCD28506030
30364-12-6 | 2-(3-methylpiperidin-2-yl)ethan-1-ol | AA01B53E | MFCD19225794
1955548-22-7 | 2-{[2-(methylsulfanyl)ethyl]amino}acetic acid hydrochloride | AA01B58M | MFCD29991997
2031260-52-1 | (2,2-difluorocyclobutyl)methanesulfonyl chloride | AA01B5CX | MFCD30344831
